Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) - Forecast to 2025

患者登録ソフトウェアの世界市場予測(〜2025):疾患登録種類別(糖尿病、希少疾患、癌、腎臓)、ソフトウェア別(統合、スタンドアロン)、展開別(オンプレミス、クラウド)、機能別(PHM、HIE)、価格モデル別、データベース別(パブリック)、エンドユーザー別(病院)

◆タイトル:Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) - Forecast to 2025
◆商品コード:HIT 3094
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年8月31日
◆ページ数:254
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:IT
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

Marketsandmarkets社は患者登録ソフトウェアの世界市場が2020年12億ドルから2025年24億ドルまで、年平均14.4%成長すると予測しています。本調査レポートでは、患者登録ソフトウェアの世界市場を調査・分析することで、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、産業見通し、疾患登録種類別(疾患登録、保健サービス登録、製品登録)分析、ソフトウェア種類別(スタンドアロン型ソフトウェア、統合型ソフトウェア)分析、価格モデル別(サブスクリプションモデル、オーナーシップモデル)分析、展開モデル別(オンプレミスモデル、クラウドモデル)分析、データベース別(商業データベース、公共データベース)分析、機能別(PHM(人口健康管理)、患者治療管理、医療研究・臨床研究、健康情報交換、POC (ポイントオブケア))分析、エンドユーザー別(政府機関・サードパーティ管理者、病院・医療者、民間保険者、製薬、バイオテクノロジー・医療機器会社)分析、地域別分析、競争状況、企業概要など、今後の市場展望をまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・産業見通し
・患者登録ソフトウェアの世界市場規模:疾患登録種類別(疾患登録、保健サービス登録、製品登録)
・患者登録ソフトウェアの世界市場規模:ソフトウェア種類別(スタンドアロン型ソフトウェア、統合型ソフトウェア)
・患者登録ソフトウェアの世界市場規模:価格モデル別(サブスクリプションモデル、オーナーシップモデル)
・患者登録ソフトウェアの世界市場規模:展開モデル別(オンプレミスモデル、クラウドモデル)
・患者登録ソフトウェアの世界市場規模:データベース別(商業データベース、公共データベース)
・患者登録ソフトウェアの世界市場規模:機能別(PHM(人口健康管理)、患者治療管理、医療研究・臨床研究、健康情報交換、POC (ポイントオブケア))
・患者登録ソフトウェアの世界市場規模:エンドユーザー別(政府機関・サードパーティ管理者、病院・医療者、民間保険者、製薬、バイオテクノロジー・医療機器会社)
・患者登録ソフトウェアの世界市場規模:地域別
・競争状況
・企業概要

“Rising adoption of electronic health records and other e-health solutions are driving market growth”
The global patient registry software market is projected to reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software. Other considerations include the rising number of accountable care organizations, high adoption of the subscription model, and the emergence of cloud-based patient registry solutions. However, shortage of trained and skilled resources and privacy and security related concerns hampered market growth to an extent.

“Diseases Registries was the largest and fastest growing segment in the type of registry market in 2019”
These registries include information on patients diagnosed with a specific disease. The main inclusion criterion that disease or condition registries use is the state of a particular disease or condition. Factors such as the Increasing government initiatives to develop and maintain patient health records (to reduce healthcare costs) and the growing awareness about collecting and utilizing patient health information are driving the adoption of disease registries. The value of disease registries is increasingly being recognized as they provide historically comparable data and long-term evaluation, potentially serving as an addition to randomized clinical trials, and thus providing insights about real-site outcomes that limited controlled studies do not address. However, the development of disease registries might become costlier as the scope of the study increases.

“Commercial Databases is the largest type of database segment in the patient registry software market in 2019”
Based on the type of database, the patient registry software market is segmented into commercial databases and public databases. A growing number of pharmaceutical/drug manufacturing and medical device companies are opting for commercial databases owing to their use in a number of studies, including the identification of adverse effects of drugs/medical devices, post-marketing surveillance, and the study of population disease patterns. . Commercial registries are generally privately funded or industry-sponsored and aim to gather patient-related data for continual delivery of quality care.

“Government organizations & TPAs is the largest end user segment in the patient registry software market in 2019”
Based on the end user, the patient registry software market is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & TPAs. In 2019, the government organizations & TPAs segment accounted for the largest share of the global patient registry software market. The large share of this segment can be attributed to the emergence of the COVID-19 pandemic and the need for analyzing patient data for better population health management.

“North America will continue to dominate the patient registry software market in 2025”
The patient registry software market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share of 48.9% of the global patient registry software market. The large share of North America in the global market is attributed to the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on PHM and HIE, increasing adoption of HCIT as a cost-containment measure, and the participation of non-profit and private organizations in improving patient care quality. Due to its growing geriatric population segment and environmental conditions have favored the spread of COVID-19 which has severely affected the region and ensured enormous growth in the demand for patient registry software. Players in this and adjacent, or even non-related, markets have focused on or collaborated for expanding the offerings of this market segment.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
• By Designation – C-level: 25%, Director-level: 20%, and Others: 55%
• By Region – North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%

Research Coverage:
The report analyzes the patient registry software market and aims at estimating the market size and future growth potential of various market segments, based on type of registry, software, pricing model, deployment model, type of database, functionality, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios of the top players in the patient registry software market. The report analyzes this market by type of registry, software, pricing model, deployment model, type of database, functionality, end user, and region.
 Market Development: Comprehensive information on the lucrative emerging markets, type of registry, software, pricing model, deployment model, type of database, functionality, end user, and region
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient registry software market
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient registry software market

【レポートの目次】

1 INTRODUCTION 37
1.1 OBJECTIVES OF THE STUDY 37
1.2 MARKET DEFINITION 38
1.2.1 INCLUSIONS & EXCLUSIONS 38
1.2.2 MARKETS COVERED 39
FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET 39
1.2.3 YEARS CONSIDERED FOR THE STUDY 40
1.3 CURRENCY 40
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 40
1.4 LIMITATIONS 40
1.5 STAKEHOLDERS 41
1.6 SUMMARY OF CHANGES 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH APPROACH 42
FIGURE 2 RESEARCH DESIGN 42
2.1.1 SECONDARY DATA 43
2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY DATA 44
FIGURE 3 PRIMARY SOURCES 44
2.1.2.1 Key data from primary sources 45
2.1.2.2 Key industry insights 46
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
2.2 MARKET SIZE ESTIMATION 47
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 48
FIGURE 6 TOP-DOWN APPROACH 49
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 50
FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY 50
2.4 MARKET SHARE ANALYSIS 50
2.5 ASSUMPTIONS FOR THE STUDY 51
3 EXECUTIVE SUMMARY 52
FIGURE 8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2020 VS. 2025 (USD MILLION) 52
FIGURE 9 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2020 VS. 2025 (USD MILLION) 53
FIGURE 10 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2020 VS. 2025 (USD MILLION) 54
FIGURE 11 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2020 VS. 2025 (USD MILLION) 55
FIGURE 12 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2020 VS. 2025 (USD MILLION) 56
FIGURE 13 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2020 VS. 2025 (USD MILLION) 57
FIGURE 14 PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 57
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PATIENT REGISTRY SOFTWARE MARKET 58
4 PREMIUM INSIGHTS 60
4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW 60
FIGURE 16 RISING ADOPTION OF ELECTRONIC HEALTH RECORDS AND OTHER E-HEALTH SOLUTIONS ARE DRIVING MARKET GROWTH 60
4.2 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY AND COUNTRY (2019) 61
FIGURE 17 DISEASE REGISTRIES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC PATIENT REGISTRY SOFTWARE MARKET IN 2019 61
4.3 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 62
FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 62
4.4 REGIONAL MIX: PATIENT REGISTRY SOFTWARE MARKET (2020−2025) 63
FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE THE PATIENT REGISTRY SOFTWARE MARKET IN 2025 63
4.5 PATIENT REGISTRY SOFTWARE MARKET: DEVELOPED VS. DEVELOPING MARKETS 63
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING
THE FORECAST PERIOD 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 21 PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
5.2.1 MARKET DRIVERS 65
5.2.1.1 Implementation of government initiatives to build patient registries 65
5.2.1.2 Rising pressure to improve the quality of care and reduce healthcare costs 65
5.2.1.3 Rising adoption of EHRs and other eHealth solutions 66
5.2.1.4 Growing patient volume due to the global outbreak of COVID-19 66
5.2.1.5 Growing use of patient registry data for post-marketing surveillance 66
5.2.2 MARKET RESTRAINTS 67
5.2.2.1 Privacy- and data security-related concerns 67
5.2.2.2 Shortage of trained and skilled resources 67
5.2.3 MARKET OPPORTUNITIES 67
5.2.3.1 Rising number of accountable care organizations 67
5.2.3.2 Emergence of cloud-based patient registry solutions 68
5.2.3.3 High adoption rate of the subscription model 68
5.2.4 MARKET CHALLENGES 68
5.2.4.1 Lack of interoperability and integration 68
5.2.4.2 Reluctance to adopt advanced solutions 68
5.2.4.3 Lack of awareness 69
6 INDUSTRY INSIGHTS 70
6.1 INTRODUCTION 70
6.2 IMPACT OF COVID-19 ON THE PATIENT REGISTRY SOFTWARE MARKET 70
TABLE 2 COVID-19 PATIENT REGISTRIES 70
6.2.1 SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS 71
6.3 HCIT EXPENDITURE ANALYSIS 72
6.3.1 NORTH AMERICA 72
TABLE 3 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY 72
6.3.2 EUROPE 72
6.3.3 ASIA PACIFIC 73
6.4 HCIT ADOPTION TRENDS IN THE US 73
FIGURE 22 US: OFFICE-BASED PHYSICIAN EHR ADOPTION (2004–2017) 73
FIGURE 23 US: HOSPITAL EHR ADOPTION (2007–2018) 74
7 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY 75
7.1 INTRODUCTION 76
TABLE 4 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2018–2025 (USD MILLION) 76
7.2 DISEASE REGISTRIES 76
TABLE 5 DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 77
TABLE 6 DISEASE REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 77
7.2.1 DIABETES REGISTRIES 78
7.2.1.1 Growing obese and geriatric populations to drive market growth 78
TABLE 7 DIABETES REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 78
TABLE 8 DIABETES REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 79
7.2.2 CARDIOVASCULAR REGISTRIES 79
7.2.2.1 Rising prevalence of heart diseases and strokes worldwide to drive market growth 79
TABLE 9 CARDIOVASCULAR REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 80
TABLE 10 CARDIOVASCULAR REGISTRIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 81
7.2.3 CANCER REGISTRIES 81
7.2.3.1 Increasing need to manage the growing number of cancer patients across the globe to propel market growth 81
TABLE 11 CANCER REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 82
TABLE 12 CANCER REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
7.2.4 RARE DISEASE REGISTRIES 83
7.2.4.1 Increasing funding for research on rare diseases and their treatments to boost market growth 83
TABLE 13 RARE DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 84
TABLE 14 RARE DISEASE REGISTRIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 84
7.2.5 ASTHMA REGISTRIES 85
7.2.5.1 Increasing prevalence of asthma is one of the major drivers for market growth 85
TABLE 15 ASTHMA REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 85
TABLE 16 ASTHMA REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 86
7.2.6 CHRONIC KIDNEY DISEASE REGISTRIES 86
7.2.6.1 Rising prevalence of chronic kidney diseases to drive market growth 86
TABLE 17 CHRONIC KIDNEY DISEASE REGISTRY SOFTWARE OFFERED
BY KEY MARKET PLAYERS/ORGANIZATIONS 87
TABLE 18 CHRONIC KIDNEY DISEASE REGISTRIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 87
7.2.7 ORTHOPEDIC REGISTRIES 88
7.2.7.1 Growing number of patients suffering from orthopedic diseases to drive market growth 88
TABLE 19 ORTHOPEDIC REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 88
TABLE 20 ORTHOPEDIC REGISTRIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 89
7.2.8 OTHER DISEASE REGISTRIES 89
TABLE 21 OTHER DISEASE REGISTRIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 90
7.3 HEALTH SERVICE REGISTRIES 90
7.3.1 THESE REGISTRIES CAPTURE SERVICE-GENERATED DATA DERIVED FROM HEALTH FACILITIES 90
TABLE 22 HEALTH SERVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 91
TABLE 23 HEALTH SERVICE REGISTRIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 92
7.4 PRODUCT REGISTRIES 92
TABLE 24 PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 92
TABLE 25 PRODUCT REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 93
7.4.1 MEDICAL DEVICE REGISTRIES 93
7.4.1.1 Strong government support and initiatives to drive the demand for medical device registries 93
TABLE 26 MEDICAL DEVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 94
TABLE 27 MEDICAL DEVICE REGISTRIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 94
7.4.2 DRUG REGISTRIES 95
7.4.2.1 Increasing post-marketing surveillance of drugs to drive market growth 95
TABLE 28 DRUGS REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS 95
TABLE 29 DRUG REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 96
8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE 97
8.1 INTRODUCTION 98
TABLE 30 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2018–2025 (USD MILLION) 98
8.2 STANDALONE SOFTWARE 98
8.2.1 STANDALONE SOFTWARE WILL CONTINUE TO DOMINATE THE MARKET IN
THE FORECAST PERIOD 98
TABLE 31 STANDALONE SOFTWARE OFFERED BY KEY MARKET PLAYERS 99
TABLE 32 STANDALONE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 100
8.3 INTEGRATED SOFTWARE 100
8.3.1 INTEGRATED SOFTWARE SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 100
TABLE 33 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS 101
TABLE 34 INTEGRATED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY
2018–2025 (USD MILLION) 102
9 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL 103
9.1 INTRODUCTION 104
TABLE 35 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 104
9.2 SUBSCRIPTION MODEL 104
9.2.1 LOW COST OF SUBSCRIPTION MODELS TO SUPPORT THE GROWTH OF
THIS SEGMENT 104
TABLE 36 SUBSCRIPTION-BASED PATIENT REGISTRY SOFTWARE MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 105
9.3 OWNERSHIP MODEL 105
9.3.1 RISING ADOPTION OF THE INTEGRATED SOFTWARE MODEL WILL SUPPORT THE GROWTH OF THIS SEGMENT 105
TABLE 37 OWNERSHIP-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 106
10 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL 107
10.1 INTRODUCTION 108
TABLE 38 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2018–2025 (USD MILLION) 108
10.2 ON-PREMISE MODEL 108
10.2.1 ON-PREMISE SOLUTIONS REDUCE THE RISK OF DATA BREACHES AND
OTHER SECURITY ISSUES 108
TABLE 39 ON-PREMISE PATIENT REGISTRY SOFTWARE OFFERED
BY KEY MARKET PLAYERS 109
TABLE 40 ON-PREMISE PATIENT REGISTRY SOFTWARE MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 110
10.3 CLOUD-BASED MODEL 110
10.3.1 CLOUD-BASED SOLUTIONS HELP HEALTHCARE ORGANIZATIONS SHARE AND INTEGRATE INFORMATION FROM DISPARATE LOCATIONS IN REAL-TIME 110
TABLE 41 CLOUD-BASED PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS 111
TABLE 42 CLOUD-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 112
11 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE 113
11.1 INTRODUCTION 114
TABLE 43 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2018–2025 (USD MILLION) 114
11.2 COMMERCIAL DATABASES 114
11.2.1 COMMERCIAL REGISTRIES ARE GENERALLY PRIVATELY FUNDED OR INDUSTRY-SPONSORED 114
TABLE 44 PATIENT REGISTRY SOFTWARE FOR COMMERCIAL DATABASES OFFERED
BY KEY MARKET PLAYERS 115
TABLE 45 PATIENT REGISTRY SOFTWARE MARKET FOR COMMERCIAL DATABASES,
BY COUNTRY, 2018–2025 (USD MILLION) 116
11.3 PUBLIC DATABASES 116
11.3.1 PUBLIC REGISTRIES ARE FUNDED BY FEDERAL, STATE, OR LOCAL GOVERNMENT AGENCIES 116
TABLE 46 PATIENT REGISTRY SOFTWARE FOR PUBLIC DATABASES OFFERED
BY KEY MARKET PLAYERS 117
TABLE 47 PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC DATABASES,
BY COUNTRY, 2018–2025 (USD MILLION) 118
12 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY 119
12.1 INTRODUCTION 120
TABLE 48 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 120
12.2 POPULATION HEALTH MANAGEMENT 120
12.2.1 INCREASING DEMAND FOR QUALITY CARE IS DRIVING THE ADOPTION OF PHM SOLUTIONS 120
TABLE 49 PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2018–2025 (USD MILLION) 121
12.3 PATIENT CARE MANAGEMENT 122
12.3.1 GOVERNMENT INITIATIVES AND REGULATIONS PROMOTING PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH 122
TABLE 50 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT, BY COUNTRY, 2018–2025 (USD MILLION) 123
12.4 MEDICAL RESEARCH & CLINICAL STUDIES 123
12.4.1 CONTINUOUS RESEARCH FOR THE COVID-19 VACCINE IS SUPPORTING
THE GROWTH OF THIS SEGMENT. 123
TABLE 51 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY COUNTRY, 2018–2025 (USD MILLION) 124
12.5 HEALTH INFORMATION EXCHANGE 124
12.5.1 INCREASING NEED FOR SHARING OF VITAL PATIENT INFORMATION WITH CARE PROVIDERS SUPPORTS ADOPTION OF SOLUTIONS 124
TABLE 52 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE, BY COUNTRY, 2018–2025 (USD MILLION) 125
12.6 POINT OF CARE 125
12.6.1 URGENT NEED FOR STREAMLINED PATIENT CARE PROCESS TO DRIVE
THE GROWTH OF THIS MARKET SEGMENT 125
TABLE 53 PATIENT REGISTRY SOFTWARE MARKET FOR POINT OF CARE, BY COUNTRY, 2018–2025 (USD MILLION) 126
12.7 PRODUCT OUTCOME EVALUATION 127
12.7.1 INCREASING POST-MARKETING SURVEILLANCE IN BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES IS LIKELY TO PROPEL MARKET GROWTH 127
TABLE 54 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT OUTCOME EVALUATION, BY COUNTRY, 2018–2025 (USD MILLION) 127
13 PATIENT REGISTRY SOFTWARE MARKET, BY END USER 128
13.1 INTRODUCTION 129
TABLE 55 PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018-2025 (USD MILLION) 129
13.2 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS 129
13.2.1 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS HOLD LARGEST SHARE IN THE END-USER MARKET 129
TABLE 56 PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT ORGANIZATIONS & TPAS, BY COUNTRY, 2018-2025 (USD MILLION) 130
13.3 HOSPITALS & MEDICAL PRACTICES 131
13.3.1 DEMAND FOR REGISTRY SOFTWARE SUPPORTED BY A GROWING FOCUS ON PATIENT SAFETY AND IMPROVING PATIENT OUTCOMES 131
TABLE 57 PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS & MEDICAL PRACTICES, BY REGION, 2018-2025 (USD MILLION) 132
13.4 PRIVATE PAYERS 132
13.4.1 NEED TO CURB RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH 132
TABLE 58 PATIENT REGISTRY SOFTWARE MARKET FOR PRIVATE PAYERS, BY REGION, 2018-2025 (USD MILLION) 133
13.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES 133
13.5.1 EVOLVING REGULATORY GUIDELINES ON PATIENT SAFETY BY REGULATORY BODIES TO PROPEL THE GROWTH OF THIS MARKET SEGMENT 133
TABLE 59 PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES, BY REGION,
2018-2025 (USD MILLION) 134
13.6 RESEARCH CENTERS 134
13.6.1 INCREASE IN CLINICAL TRIALS & RESEARCH ON DISEASE TREATMENT SUPPORTS THE GROWTH OF THIS MARKET SEGMENT 134
TABLE 60 PATIENT REGISTRY SOFTWARE MARKET FOR RESEARCH CENTERS,
BY REGION, 2018-2025 (USD MILLION) 135
14 PATIENT REGISTRY SOFTWARE MARKET, BY REGION 136
14.1 INTRODUCTION 137
FIGURE 24 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 137
TABLE 61 PATIENT REGISTRY SOFTWARE MARKET, BY REGION,
2018–2025 (USD MILLION) 138
14.2 NORTH AMERICA 138
FIGURE 25 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT 139
TABLE 62 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 140
TABLE 63 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 140
TABLE 64 NORTH AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 140
TABLE 65 NORTH AMERICA: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 141
TABLE 66 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 141
TABLE 67 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY PRICING MODEL, 2018–2025 (USD MILLION) 142
TABLE 68 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 142
TABLE 69 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 142
TABLE 70 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY FUNCTIONALITY, 2018–2025 (USD MILLION) 143
TABLE 71 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY END USER, 2018–2025 (USD MILLION) 143
14.2.1 US 143
14.2.1.1 The US is the largest market for patient registry software 143
TABLE 72 US: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 144
TABLE 73 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2018–2025 (USD MILLION) 144
TABLE 74 US: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 145
TABLE 75 US: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 145
TABLE 76 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2018–2025 (USD MILLION) 146
TABLE 77 US: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 146
TABLE 78 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2018–2025 (USD MILLION) 146
TABLE 79 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2018–2025 (USD MILLION) 147
TABLE 80 US: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 147
TABLE 81 US: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 148
14.2.2 CANADA 148
14.2.2.1 Launch of new government initiatives is expected to drive
the adoption of patient registry software across the country 148
TABLE 82 CANADA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 149
TABLE 83 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 149
TABLE 84 CANADA: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 149
TABLE 85 CANADA: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 86 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 150
TABLE 87 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018–2025 (USD MILLION) 151
TABLE 88 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 151
TABLE 89 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 151
TABLE 90 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 152
TABLE 91 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 152
14.3 EUROPE 153
TABLE 92 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION) 153
TABLE 93 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 153
TABLE 94 EUROPE: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 154
TABLE 95 EUROPE: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 154
TABLE 96 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 155
TABLE 97 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018–2025 (USD MILLION) 155
TABLE 98 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 155
TABLE 99 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 156
TABLE 100 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 156
TABLE 101 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 157

14.3.1 UK 157
14.3.1.1 Government initiatives to support market growth 157
TABLE 102 UK: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 158
TABLE 103 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2018–2025 (USD MILLION) 158
TABLE 104 UK: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 105 UK: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 159
TABLE 106 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2018–2025 (USD MILLION) 159
TABLE 107 UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 160
TABLE 108 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,
2018–2025 (USD MILLION) 160
TABLE 109 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2018–2025 (USD MILLION) 160
TABLE 110 UK: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 161
TABLE 111 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 161
14.3.2 GERMANY 161
14.3.2.1 High healthcare spending to support the adoption of patient registry software solutions in Germany 161
TABLE 112 GERMANY: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 162
TABLE 113 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 162
TABLE 114 GERMANY: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 163
TABLE 115 GERMANY: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 163
TABLE 116 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 164
TABLE 117 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018–2025 (USD MILLION) 164
TABLE 118 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 164
TABLE 119 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 165
TABLE 120 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION) 165
TABLE 121 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 166
14.3.3 FRANCE 166
14.3.3.1 Large number of COVID-19 cases to support market growth 166
TABLE 122 FRANCE: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 166
TABLE 123 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 167
TABLE 124 FRANCE: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 167
TABLE 125 FRANCE: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 168
TABLE 126 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 168
TABLE 127 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018–2025 (USD MILLION) 169
TABLE 128 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 169
TABLE 129 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 169
TABLE 130 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 170
TABLE 131 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 170
14.3.4 ITALY 171
14.3.4.1 Rising prevalence of chronic diseases to increase the demand for patient registry software 171
TABLE 132 ITALY: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 171
TABLE 133 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2018–2025 (USD MILLION) 171
TABLE 134 ITALY: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 135 ITALY: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 172
TABLE 136 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 173
TABLE 137 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 173
TABLE 138 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 173
TABLE 139 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2018–2025 (USD MILLION) 174
TABLE 140 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 174
TABLE 141 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 175
14.3.5 SPAIN 175
14.3.5.1 Government initiatives to improve the adoption of patient registry software and eHealth solutions are major market drivers 175
TABLE 142 SPAIN: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 176
TABLE 143 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 176
TABLE 144 SPAIN: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 176
TABLE 145 SPAIN: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 177
TABLE 146 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 177
TABLE 147 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 178
TABLE 148 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 178
TABLE 149 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 178
TABLE 150 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 179
TABLE 151 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 179
14.3.6 REST OF EUROPE 179
TABLE 152 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2018–2025 (USD MILLION) 180
TABLE 153 ROE: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 180
TABLE 154 ROE: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 181
TABLE 155 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,
2018–2025 (USD MILLION) 181
TABLE 156 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 182
TABLE 157 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 182
TABLE 158 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,
2018–2025 (USD MILLION) 182
TABLE 159 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 183
TABLE 160 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 183
14.4 ASIA PACIFIC 184
FIGURE 26 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT 185
TABLE 161 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 186
TABLE 162 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 186
TABLE 163 ASIA PACIFIC: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 186
TABLE 164 ASIA PACIFIC: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 187
TABLE 165 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 187
TABLE 166 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET,
BY PRICING MODEL, 2018–2025 (USD MILLION) 188
TABLE 167 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET,
BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 188
TABLE 168 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 188
TABLE 169 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET,
BY FUNCTIONALITY, 2018–2025 (USD MILLION) 189
TABLE 170 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET,
BY END USER, 2018–2025 (USD MILLION) 189
14.4.1 JAPAN 190
14.4.1.1 Japan has one of the highest adoption rates of EMR and patient registry software solutions in the Asia Pacific 190
TABLE 171 JAPAN: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 190
TABLE 172 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 191
TABLE 173 JAPAN: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 191
TABLE 174 JAPAN: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 192
TABLE 175 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 192
TABLE 176 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 193
TABLE 177 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 193
TABLE 178 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 193
TABLE 179 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 194
TABLE 180 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 194
14.4.2 CHINA 195
14.4.2.1 Absence of a patient-centered model may challenge the adoption of patient registry software and related markets in the country 195
TABLE 181 CHINA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 195
TABLE 182 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 196
TABLE 183 CHINA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 196
TABLE 184 CHINA: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 197
TABLE 185 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 197
TABLE 186 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 198
TABLE 187 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 198
TABLE 188 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 198
TABLE 189 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 199
TABLE 190 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 199
14.4.3 INDIA 200
14.4.3.1 India is currently one of the lucrative emerging regions in the field of eHealth 200
TABLE 191 INDIA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET 200
TABLE 192 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,
2018–2025 (USD MILLION) 201
TABLE 193 INDIA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 201
TABLE 194 INDIA: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION) 202
TABLE 195 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 202
TABLE 196 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,
2018–2025 (USD MILLION) 203
TABLE 197 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 203
TABLE 198 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 203
TABLE 199 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 204
TABLE 200 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 204
14.4.4 REST OF ASIA PACIFIC 205
TABLE 201 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 205
TABLE 202 ROAPAC: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 206
TABLE 203 ROAPAC: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 206
TABLE 204 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 207
TABLE 205 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018–2025 (USD MILLION) 207
TABLE 206 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 207
TABLE 207 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 208
TABLE 208 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,
2018–2025 (USD MILLION) 208
TABLE 209 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,
2018–2025 (USD MILLION) 209
14.5 LATIN AMERICA 209
14.5.1 LATIN AMERICA HAS A LOWER ADOPTION RATE OF EHR SOLUTIONS 209
TABLE 210 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 210
TABLE 211 LATIN AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 210
TABLE 212 LATIN AMERICA: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 211
TABLE 213 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 211
TABLE 214 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY PRICING MODEL, 2018–2025 (USD MILLION) 212
TABLE 215 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 212
TABLE 216 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 212
TABLE 217 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION) 213
TABLE 218 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET,
BY END USER, 2018–2025 (USD MILLION) 213
14.6 MIDDLE EAST & AFRICA 214
14.6.1 IMPLEMENTATION OF PATIENT REGISTRY SOFTWARE ACROSS PRIVATE SECTORS HAS BEEN EXTREMELY SLOW PACED 214
TABLE 219 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF REGISTRY, 2018–2025 (USD MILLION) 214
TABLE 220 MIDDLE EAST & AFRICA: PRODUCT REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 215
TABLE 221 MIDDLE EAST & AFRICA: DISEASE REGISTRIES MARKET, BY TYPE,
2018–2025 (USD MILLION) 215
TABLE 222 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION) 216
TABLE 223 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY PRICING MODEL, 2018–2025 (USD MILLION) 216
TABLE 224 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION) 216
TABLE 225 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY TYPE OF DATABASE, 2018–2025 (USD MILLION) 217
TABLE 226 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY FUNCTIONALITY, 2018–2025 (USD MILLION) 217
TABLE 227 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET,
BY END USER, 2018–2025 (USD MILLION) 218
15 COMPETITIVE LANDSCAPE 219
15.1 OVERVIEW 219
FIGURE 27 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES 219
15.2 COMPETITIVE LEADERSHIP MAPPING 220
15.2.1 STARS 220
15.2.2 EMERGING LEADERS 220
15.2.3 PERVASIVE COMPANIES 220
15.2.4 EMERGING COMPANIES 220
FIGURE 28 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 221
15.3 PRODUCT MATRIX, BY COMPANY 222
FIGURE 29 R&D EXPENDITURE BY KEY PLAYERS IN THE PATIENT REGISTRY SOFTWARE MARKET, 2018 VS. 2019 (USD MILLION) 223
15.4 MARKET SHARE ANALYSIS 223
FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET RANKING ANALYSIS, BY PLAYER, 2019 223
15.5 COMPETITIVE SITUATIONS & TRENDS 224
15.5.1 PRODUCT LAUNCHES 224
TABLE 228 KEY PRODUCT LAUNCHES 224
15.5.2 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 225
TABLE 229 KEY PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 225
15.5.3 ACQUISITIONS 225
TABLE 230 KEY ACQUISITIONS 225
16 COMPANY PROFILES 226
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
16.1 PHYTEL 226
FIGURE 31 IBM CORPORATION: COMPANY SNAPSHOT 226
16.2 IQVIA HOLDINGS 229
FIGURE 32 IQVIA HOLDINGS: COMPANY SNAPSHOT (2019) 229
16.3 OPENTEXT CORPORATION 232
FIGURE 33 OPENTEXT CORPORATION: COMPANY SNAPSHOT (2019) 232
16.4 SYNEOS HEALTH 234
FIGURE 34 SYNEOS HEALTH: COMPANY SNAPSHOT (2019) 234
16.5 FIGMD 236
16.6 IMAGETREND 238
16.7 CECITY.COM 239
FIGURE 35 PREMIER: COMPANY SNAPSHOT 239
16.8 DACIMA SOFTWARE 241
16.9 GLOBAL VISION TECHNOLOGIES 242
16.10 IFA SYSTEMS AG 243
FIGURE 36 IFA SYSTEMS AG: COMPANY SNAPSHOT (2018) 243
16.11 M2S 244
16.12 MCKESSON CORPORATION 245
FIGURE 37 MCKESSON CORPORATION: COMPANY SNAPSHOT (2020) 245
16.13 OPTUM 247
FIGURE 38 OPTUM: COMPANY SNAPSHOT (2019) 247
16.14 EVADO CLINICAL 249
16.15 VELOS 250
16.16 ARBORMETRIX 251
16.17 LUMEDX 252
16.18 HEALTHDIARY 252
16.19 CEDARON 252
16.20 PHAMAX AG 253
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

17 APPENDIX 254
17.1 INSIGHTS FROM INDUSTRY EXPERTS 254
17.2 DISCUSSION GUIDE 255
17.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 260
17.4 AVAILABLE CUSTOMIZATIONS 262
17.5 RELATED REPORTS 262
17.6 AUTHOR DETAILS 263

★調査レポート[患者登録ソフトウェアの世界市場予測(〜2025):疾患登録種類別(糖尿病、希少疾患、癌、腎臓)、ソフトウェア別(統合、スタンドアロン)、展開別(オンプレミス、クラウド)、機能別(PHM、HIE)、価格モデル別、データベース別(パブリック)、エンドユーザー別(病院)] ( Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) - Forecast to 2025 / HIT 3094) 販売に関する免責事項
[患者登録ソフトウェアの世界市場予測(〜2025):疾患登録種類別(糖尿病、希少疾患、癌、腎臓)、ソフトウェア別(統合、スタンドアロン)、展開別(オンプレミス、クラウド)、機能別(PHM、HIE)、価格モデル別、データベース別(パブリック)、エンドユーザー別(病院)] ( Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) - Forecast to 2025 / HIT 3094) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆